Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
CataractSurgeryCompliance, PatientCompliance, MedicationSatisfaction, Patient
Interventions
DRUG

Dropless Regimen

"Intraoperative subconjunctival injection of triamcinolone acetonide (20mg) delivered 4-5 mm posterior to the limbus at the end of surgery.~Intraoperative intracameral injection of cefuroxime delivered at the end of surgery.~No postoperative drops."

DRUG

Standard Regimen

"Intraoperative intracameral injection of cefuroxime delivered at the end of surgery.~Neomycin/Polymyxin B ophthalmic solution: one drop to the operative eye four times daily for 1 week, then stop.~Ketorolac 0.5% ophthalmic solution: one drop to the operative eye four times daily for 1 month or until the bottle runs out.~Prednisolone acetate 1% ophthalmic solution: one drop to the operative eye four times daily for 1 month, then stop."

Trial Locations (1)

94110

RECRUITING

Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG), San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER